Skip to Content

User Reviews for Larotrectinib

Also known as: Vitrakvi

Condition Avg. Rating Reviews Compare
Solid Tumors 1 reviews 12 medications

Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.

jed zeplix · Taken for 1 to 6 months May 14, 2019

Vitrakvi (larotrectinib) for Solid Tumors: “I've only been taking Vitrakvi a couple months, for squamous cell cancer in left head and neck after already having chemo and radiation , with no fresh scans I can't say anything about effectiveness but I'm not expecting much of a turn around if at all , mainly because of negative prognosis. But I can say I haven't had any bad side effects , but I didn't with chemo either, lucky I guess. No nausea or anything like that so I would say don't concern over that . Good luck. Thank you Bayer very much for the opportunity .”

This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.